Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.55 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21838299 | 1.00 | NOD1 (0.55) | NOD1PLA2G2CKMT2APLA2G10POLB | |
| SCHEMBL9762130 | 1.00 | NOD1 (0.55) | NOD1PLA2G2CKMT2APLA2G10POLB | |
| SCHEMBL155010 | 1.00 | NOD1 (0.55) | NOD1PLA2G2CKMT2APLA2G10POLB | |
| Adipic Acid SCHEMBL29008920 | 0.93 | KMT2A (0.59) | NOD1PLA2G2CKMT2APLA2G10POLB | |
| SCHEMBL3773057 | 0.92 | PLA2G2C (0.56) | NOD1PLA2G2CKMT2APLA2G10POLB | |
| SCHEMBL9762120 | 0.90 | KMT2A (0.64) | NOD1PLA2G2CKMT2APOLBFAAH | |
| SCHEMBL9762126 | 0.90 | KMT2A (0.64) | NOD1PLA2G2CKMT2APOLBFAAH | |
| SCHEMBL29129967 | 0.90 | KMT2A (0.64) | NOD1PLA2G2CKMT2APOLBFAAH | |
| SCHEMBL155009 | 0.90 | KMT2A (0.64) | NOD1PLA2G2CKMT2APOLBFAAH | |
| SCHEMBL155007 | 0.90 | KMT2A (0.64) | NOD1PLA2G2CKMT2APOLBFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240148616-A1 | WATER-IN-OIL EMULSION COMPOSITION, COSMETIC, AND METHOD FOR PREPARING WATER-IN-OIL EMULSION COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| US-20240009091-A1 | OIL-IN-WATER-TYPE COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2024-01-11 | — | — | US | disclosed |
| EP-4286015-A1 | OIL-IN-WATER-TYPE EMULSION COSMETIC | Kao Corporation (JP) | 2023-12-06 | — | — | EP | disclosed |
| WO-2023210084-A1 | COSMETIC | 株式会社 資生堂 | 2023-11-02 | — | — | WO | disclosed |
| WO-2023162812-A1 | OIL-IN-WATER TYPE COSMETIC | 株式会社 資生堂 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023120204-A1 | OIL-IN-WATER EMULSION COSMETIC | 株式会社 資生堂 | 2023-06-29 | — | — | WO | disclosed |
| WO-2023079977-A1 | SUNSCREEN COSMETIC | 株式会社 資生堂 | 2023-05-11 | — | — | WO | disclosed |
| EP-4017537-A1 | SILK PERSONAL CARE COMPOSITIONS | Evolved by Nature, Inc. (US) | 2022-06-29 | — | — | EP | disclosed |
| WO-2021112208-A1 | OIL-IN-WATER EMULSION SUNSCREEN COMPOSITION | 株式会社 資生堂 | 2021-06-10 | — | — | WO | disclosed |
| WO-2021035087-A1 | SILK PERSONAL CARE COMPOSITIONS | EVOLVED BY NATURE, INC. (US) | 2021-02-25 | — | — | WO | disclosed |
| WO-2020218176-A1 | COSMETIC RAW MATERIAL | 株式会社 資生堂 | 2020-10-29 | — | — | WO | disclosed |
| WO-2020158667-A1 | MILKY COSMETIC | 株式会社 資生堂 | 2020-08-06 | — | — | WO | disclosed |
| WO-2020032151-A1 | METHOD FOR PRODUCING COATING FILM | 花王株式会社 | 2020-02-13 | — | — | WO | disclosed |
| WO-2019203041-A1 | CLEANSER COMPOSITION | 株式会社 資生堂 | 2019-10-24 | — | — | WO | disclosed |
| WO-2019203040-A1 | CLEANSER COMPOSITION | 株式会社 資生堂 | 2019-10-24 | — | — | WO | disclosed |
| CN-103356403-B | Cosmetic | 信越化学工业株式会社 | 2017-07-28 | — | — | CN | disclosed |
| CN-103319720-B | Organopolysiloxane and manufacture method thereof, cosmetic containing organopolysiloxane | SHIN-ETSU CHEMICAL INDUSTRY CO., LTD. (JP) | 2016-03-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148616-A1 | WATER-IN-OIL EMULSION COMPOSITION, COSMETIC, AND METHOD FOR PREPARING WATER-IN-OIL EMULSION COMPOSITION | CUTA, LAGE3, TES | NOD1 4657/4885PLA2G2C 712/4885KMT2A 1402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.